News

Clinical Trials Arena on MSN9d
Cellphire Therapeutics halts enrolment in trial of CLPH-511 after IDMC feedback
The company expects the final trial visits and the collection of data to take place by the second quarter of this year.
TipRanks on MSN3mon
uniQure says IDMC recommends proceeding with dose escalation in AMT-162 trial
uniQure (QURE) announced that the Independent Data Monitoring Committee for EPISOD1 ... day safety data from the first study ...
Nasdaq9d
Rezolute Gets Positive DMC Review For Phase 3 Ersodetug Trial In Congenital HI
(RTTNews) - Rezolute, Inc. (RZLT) on Wednesday announced that an independent Data Monitoring Committee or DMC has issued a positive recommendation for the ongoing Phase 3 sunRIZE study of ...
Yahoo Finance9d
Cellphire Therapeutics halts enrolment in trial of CLPH-511 after IDMC feedback
US-based biotechnology company Cellphire Therapeutics has stopped enrolling subjects in its CRYPTICS trial of CLPH-511 following feedback from an independent data monitoring committee. The ...